本文選題：VEGF + 腦缺血　； 參考：《南開(kāi)大學(xué)》2014年博士論文

【摘要】：目的 (1)通過(guò)在體(in vivo)實(shí)驗(yàn)觀察外源性血管內(nèi)皮生長(zhǎng)因子VEGF對(duì)慢性低灌注型腦缺血模型大鼠認(rèn)知功能的保護(hù)作用及電生理學(xué)和組織學(xué)機(jī)制。 (2)利用離體(in vitro)海馬腦片缺血缺氧模型探討VEGF對(duì)海馬神經(jīng)元保護(hù)作用的細(xì)胞學(xué)及電生理學(xué)機(jī)制。 方法 (1)In vivo:將30只雄性Wistar大鼠隨機(jī)分成3組,每組10只：假手術(shù)組(Sham)、缺血組(Ischemia)、VEGF處理組(Ischemia+VEGF)。采用雙側(cè)頸總動(dòng)脈結(jié)扎(2-VO)2周建立慢性低灌注型腦缺血大鼠模型。采用鼻飼法給予外源性VEGF,然后利用Morris水迷宮實(shí)驗(yàn)(MWM)比較各組大鼠的空間認(rèn)知功能；行為學(xué)實(shí)驗(yàn)后,進(jìn)行電生理實(shí)驗(yàn),內(nèi)容包括海馬CA3-CA1區(qū)的長(zhǎng)時(shí)程增強(qiáng)LTP以及局部場(chǎng)電位(LFP),并應(yīng)用神經(jīng)信息流算法分析各組大鼠CA3與CA1區(qū)神經(jīng)網(wǎng)絡(luò)的振蕩模態(tài)的變化。實(shí)驗(yàn)結(jié)束后取腦,使用ELISA的方法測(cè)定各組海馬內(nèi)VEGF的含量并通過(guò)組織學(xué)方法(HE染色)觀察海馬CA1區(qū)錐體細(xì)胞的形態(tài)結(jié)構(gòu)。 (2) In vitro:首先利用糖氧剝奪(OGD)的方法建立離體缺血缺氧海馬腦片模型,實(shí)驗(yàn)分為4組,即正常組(Control)、糖氧剝奪組(OGD)、VEGF處理組(OGD+VEGF)、VEGF及其受體抑制劑處理組(OGD+VEGF+SU5416)。使用碘化丙啶(PI)染色的方法并利用共聚焦顯微鏡觀察各組腦片海馬CA1區(qū)神經(jīng)元在OGD處理20min后的存活情況。然后分別記錄各組腦片在OGD處理10min以及恢復(fù)正常腦脊液后的電生理信號(hào)的變化,包括神經(jīng)元膜電位、自發(fā)放電頻率以及sEPSCs的變化。 結(jié)果 (1)水迷宮(MWM)實(shí)驗(yàn)結(jié)果發(fā)現(xiàn),缺血組大鼠的逃避潛伏期從訓(xùn)練的第3天開(kāi)始比假手術(shù)組顯著延長(zhǎng)(Ischemia:13.5±1.9s vs. Sham:8.1±1.2s,P0.05),而VEGF處理后的腦缺血大鼠的逃避潛伏期也從第3天開(kāi)始比缺血組大鼠明顯地縮短了(Ischemia+VEGF:8.5±1.1s, P0.05vs. Ischemia);但是,三組大鼠的平均游泳速度無(wú)顯著性差別(P0.05)。測(cè)試日的實(shí)驗(yàn)發(fā)現(xiàn),缺血組大鼠在目標(biāo)象限停留的百分比比假手術(shù)組的大鼠明顯減少(Ischemia:34.2±1.6%vs. Sham:42.9±1.5%, P0.05), VEGF處理后缺血大鼠的目標(biāo)象限百分比幾乎恢復(fù)到假手術(shù)組的水平(Ischemia+VEGF:40.1±2.6%). (2)記錄并分析各組大鼠海馬CA3-CA1通路的長(zhǎng)時(shí)程增強(qiáng)LTP的結(jié)果發(fā)現(xiàn),缺血組的場(chǎng)興奮性突觸后電位(fEPSPs)斜率百分比比假手術(shù)組顯著降低(Ischemia:117.8±6.23%vs. Sham:136.2±5.96%,P0.01),而VEGF組則比缺血組明顯要高(130.6±5.36%, P0.01vs. Ischemia)。 (3)記錄并計(jì)算各組大鼠海馬CA3與CA1區(qū)局部場(chǎng)電位(LFP)的結(jié)果發(fā)現(xiàn),腦缺血能夠引起海馬CA3與CA1腦區(qū)間的相位同步性降低,CA3區(qū)theta相位調(diào)控CA1低頻gamma(LG,30-60Hz)幅值的程度顯著降低,而加入VEGF后,CA3、CA1腦區(qū)間的耦合強(qiáng)度均有上升的趨勢(shì)。 (4)HE染色結(jié)果發(fā)現(xiàn),假手術(shù)組大鼠海馬CA1區(qū)錐體神經(jīng)元形態(tài)正常。而缺血組的CA1神經(jīng)元排列松散,分布不均,細(xì)胞出現(xiàn)水腫以及核固縮的現(xiàn)象。而VEGF處理組大鼠的CA1神經(jīng)元可見(jiàn)部分形態(tài)正常,部分形態(tài)異常,分布及排列趨近于正常組。 (5)分析各組大鼠海馬內(nèi)VEGF的含量發(fā)現(xiàn),缺血組大鼠海馬內(nèi)的VEGF含量明顯比假手術(shù)組要低(Sham:745.33±42.34pg/g vs. Ischemia:420.09±40.82pg/g,P0.01),而VEGF處理組的海馬內(nèi)的VEGF含量有顯著提高(592.83±38.76pg/g, P0.05vs. Ischemia),但仍然低于假手術(shù)組(P0.05)。 (6)在離體實(shí)驗(yàn)中檢測(cè)各組腦片海馬CA1神經(jīng)元存活情況的結(jié)果發(fā)現(xiàn),OGD處理20min后,神經(jīng)元的死亡率顯著上升(Control vs. OGD, P0.05),而VEGF孵育組存活細(xì)胞的數(shù)量增多,接近正常組。然而與VEGFR-2的抑制劑SU5416共孵育之后,神經(jīng)元的死亡率升高,接近OGD組。 (7)膜片鉗實(shí)驗(yàn)發(fā)現(xiàn),OGD處理后CA1神經(jīng)元的電生理特性能夠發(fā)生可逆性變化的時(shí)間窗口為10min,在恢復(fù)正常aCSF處理后絕大部分神經(jīng)元的膜電位能夠恢復(fù)正常,因此將其確定為本實(shí)驗(yàn)的時(shí)間窗口。 (8)在10min OGD處理期間分析各組神經(jīng)元的興奮性發(fā)現(xiàn),OGD組神經(jīng)元的膜電位在OGD結(jié)束時(shí)去極化了14.7±1.23mV(n=5),而VEGF處理組神經(jīng)元?jiǎng)t去極化了6.1±1.57mV (n=8, OGD vs. OGD+VEGF, P0.01)。同時(shí)共孵育VEGFR-2抑制劑SU5416組(OGD+VEGF+SU5416)則去極化了12.1±1.92mV(n=6)。同樣的在自發(fā)放電頻率的統(tǒng)計(jì)結(jié)果中發(fā)現(xiàn),OGD+VEGF組的神經(jīng)元的在OGD期間的自發(fā)放電頻率比base時(shí)增加了5.1±0.6倍,遠(yuǎn)遠(yuǎn)低于OGD組(9.2±0.56倍,P0.01,n=5),而OGD+VEGF+SU5416放電頻率增加了8.1±0.47倍,高于VEGF處理組且具有顯著差異(P0.01,n=5),但是與OGD組相比卻不具有統(tǒng)計(jì)學(xué)差異(P0.05)。 (9)在記錄并分析了各組大鼠海馬CA1神經(jīng)元的sEPSCs事件結(jié)果發(fā)現(xiàn),在10min OGD處理期間,各組sEPSCs的幅值和頻率均時(shí)間依賴(lài)性的增加,而在VEGF處理組,這兩個(gè)指標(biāo)增加的程度被緩解,但仍不能恢復(fù)到正常水平。而加入VEGF受體抑制劑SU5416之后,VEGF的緩解效果被解除,說(shuō)明VEGF的作用是通過(guò)VEGFR-2受體發(fā)揮作用的。 結(jié)論 (1)外源性給予VEGF可顯著改善VD大鼠的空間認(rèn)知障礙,其機(jī)制包括改善缺血大鼠海馬錐體神經(jīng)元水腫和核固縮情況,維持海馬神經(jīng)元正常功能。 (2)通過(guò)鼻飼法給予外源性VEGF是一種可行的方法,可以使缺血大鼠海馬內(nèi)VEGF的含量有效升高,對(duì)缺血產(chǎn)生了保護(hù)作用。 (3) VEGF能夠改善VD大鼠海馬內(nèi)突觸可塑性的降低,增強(qiáng)CA3-CA1的長(zhǎng)時(shí)程增強(qiáng)LTP,這一現(xiàn)象可能與VEGF改善了它們之間theta節(jié)律與gamma節(jié)律的交叉耦合模式有關(guān)。 (4)在離體缺血缺氧腦片模型中,外源性VEGF能夠通過(guò)其VEGFR-2受體來(lái)發(fā)揮對(duì)海馬神經(jīng)元的保護(hù)作用,其機(jī)制是對(duì)抗缺氧導(dǎo)致的神經(jīng)元凋亡,從而促進(jìn)其存活。 (5)VEGF能夠?qū)褂扇毖跻鸬暮ｑRCA1神經(jīng)元興奮性的升高,維持了神經(jīng)元的正常電生理特性,這可能是VEGF在缺血早期發(fā)揮保護(hù)作用的電生理學(xué)機(jī)制。 (6)VEGF能夠降低由缺氧引起的海馬神經(jīng)元突觸傳遞的異常升高,維持了神經(jīng)元正常的突觸傳遞功能,這可能是VEGF能夠改善突觸可塑性并進(jìn)一步改善認(rèn)知功能的機(jī)制之一。
[Abstract]:objective
(1) the protective effect of exogenous vascular endothelial growth factor VEGF on cognitive function of chronic hypoplastic cerebral ischemia model rats and the electrophysiological and histological mechanism were observed by the in vivo experiment.
(2) the cellular and electrophysiological mechanisms of VEGF on hippocampal neurons were studied by using in vitro hippocampal slices.
Method
(1) In vivo: randomly divided 30 male Wistar rats into 3 groups, with 10 rats in each group: the sham operation group (Sham), the ischemic group (Ischemia) and the VEGF treatment group (Ischemia+VEGF). The rat model of chronic low perfusion cerebral ischemia was established by bilateral common carotid artery ligation (2-VO) for 2 weeks. The exogenous VEGF was given by the nasal feeding method, and the Morris water maze test (MWM) ratio was used. The spatial cognitive function of the rats in each group was compared. After the behavior experiment, the electrophysiological experiments were carried out, including the long time enhancement LTP and the local field potential (LFP) in the hippocampal CA3-CA1 region, and the changes of the oscillatory modes of the CA3 and CA1 neural networks in each group were analyzed by the neural information flow algorithm. The brain was taken after the experiment and the method of ELISA was used. The content of VEGF in hippocampus of each group was determined, and the morphological structure of pyramidal cells in hippocampus CA1 was observed by histological method (HE staining).
(2) In vitro: first used the method of glucose oxygen deprivation (OGD) to establish an isolated ischemic hypoxic hippocampal slice model. The experiment was divided into 4 groups, namely, normal group (Control), glucose oxygen deprivation group (OGD), VEGF treatment group (OGD+VEGF), VEGF and its receptor inhibitor treatment group (OGD+VEGF+ SU5416). The method of staining with propidium iodide (PI) was used and confocal microscopy was used. The survival of hippocampal CA1 neurons in each group was observed after OGD treatment of 20min. The changes of electrophysiological signals in each group of brain slices after OGD treatment and recovery of normal cerebrospinal fluid were recorded, including the neuronal membrane potential, spontaneous discharge frequency and the change of sEPSCs.
Result
(1) the results of water maze (MWM) experiment found that the escape latency of rats in the ischemic group was significantly longer than that of the sham group (Ischemia:13.5 + 1.9s vs. Sham:8.1 + 1.2s, P0.05), and the escape latency of ischemic rats after VEGF treatment was also significantly shorter than that of the ischemic group (Ischemia+VEGF:8.5 + 1.1s). P0.05vs. Ischemia); however, the average swimming speed of the three groups was not significantly different (P0.05). The test day showed that the percentage of the rats in the ischemic group was significantly lower than that of the sham group (Ischemia:34.2 + 1.6%vs. Sham:42.9 + 1.5%, P0.05). The percentage of the target quadrants of the ischemic rats after VEGF treatment was few. It returned to the level of the sham operation group (Ischemia+VEGF:40.1 + 2.6%).
(2) the results of recording and analyzing the long time enhanced LTP of the CA3-CA1 pathway in the hippocampus of rats showed that the percentage of the field excitatory postsynaptic potential (fEPSPs) slope in the ischemic group was significantly lower than that of the sham group (Ischemia:117.8 + 6.23%vs. Sham:136.2 + 5.96%, P0.01), while VEGF group was significantly higher than that of the ischemic group (130.6 + 5.36%, P0.01vs. Ischemia).
(3) the results of recording and calculating the local field potential (LFP) of CA3 and CA1 regions in the hippocampus of rats were recorded and calculated. It was found that cerebral ischemia could cause the phase synchronization of CA3 and CA1 in the hippocampus to be reduced, and the degree of low frequency gamma (LG, 30-60Hz) amplitude of CA1 in CA3 region theta phase regulated significantly decreased. Potential.
(4) the results of HE staining showed that the hippocampal pyramidal neurons in the hippocampal CA1 area of the sham operation group were normal, while the CA1 neurons in the ischemic group were loosely arranged and distributed unevenly. The cells appeared edema and nuclear condensation. The CA1 neurons in the VEGF treatment group showed normal part of the morphology, and the partial morphology was abnormal. The distribution and arrangement of the CA1 neurons were close to the normal group.
(5) the content of VEGF in hippocampus of rats in each group was analyzed. The content of VEGF in hippocampus of ischemia group was significantly lower than that of sham group (Sham:745.33 + 42.34pg/g vs. Ischemia:420.09 + 40.82pg/g, P0.01), while the VEGF content in the hippocampus of the VEGF treatment group was significantly increased (592.83 + 38.76pg/g, P0.05vs.), but still lower than the sham operation group. P0.05).
(6) the results of the survival of hippocampal CA1 neurons in each group were detected in isolated experiments. It was found that after OGD treatment 20min, the mortality of neurons increased significantly (Control vs. OGD, P0.05), while the number of surviving cells in the VEGF incubating group increased, close to that of the normal group. However, the mortality of neurons increased after reincubation with the inhibitor SU5416 of VEGFR-2. Close to group OGD.
(7) the patch clamp experiment found that the time window for the electrophysiological characteristics of CA1 neurons after OGD treatment was 10min. The membrane potential of most of the neurons was restored to normal after the recovery of normal aCSF, so it was determined as the time window of this experiment.
(8) the excitability of neurons in each group was analyzed during the 10min OGD treatment. The membrane potential of the neurons in group OGD was 14.7 + 1.23mV (n=5) at the end of OGD, while the neurons in the VEGF treatment group depolarized 6.1 + 1.57mV (n=8, OGD vs. OGD+VEGF). 1.92mV (n=6). In the same statistical results of spontaneous discharge frequency, the spontaneous discharge frequency of neurons in group OGD+VEGF increased by 5.1 + 0.6 times than that of base, far lower than that of OGD group (9.2 + 0.56 times, P0.01, n=5), and OGD+VEGF+SU5416 discharge frequency increased by 8.1 + 0.47 times, higher than that of VEGF treatment group with significant difference (P0.0) 1, n=5), but there was no statistical difference compared with group OGD (P0.05).
(9) the results of sEPSCs event of hippocampal CA1 neurons in each group were recorded and analyzed. The amplitude and frequency of sEPSCs in each group increased during 10min OGD treatment, while in VEGF treatment group, the increase of these two indexes was relieved, but still could not be restored to normal level. After SU5416, the VEGF receptor inhibitor SU5416 was added. The relieving effect of VEGF was relieved, indicating that VEGF plays a role through VEGFR-2 receptors.
conclusion
(1) exogenous VEGF can significantly improve the spatial cognitive impairment of VD rats. The mechanism includes improving hippocampal pyramidal neuron edema and nuclear pyknosis in ischemic rats and maintaining normal function of hippocampal neurons.
(2) giving exogenous VEGF through nasal feeding is a feasible method, which can effectively increase the content of VEGF in the hippocampus of ischemic rats and protect against ischemia.
(3) VEGF can improve the decrease of synaptic plasticity in the hippocampus of VD rats and enhance the long term enhanced LTP of CA3-CA1. This phenomenon may be related to the improvement of the cross coupling mode between theta rhythm and gamma rhythm with VEGF.
(4) in the isolated ischemic hypoxic brain model, exogenous VEGF can play a protective role in hippocampal neurons through its VEGFR-2 receptor, and its mechanism is to antagonize the apoptosis of neurons induced by hypoxia and thus promote its survival.
(5) VEGF can antagonize the increase of excitatory activity of hippocampal CA1 neurons caused by hypoxia and maintain the normal electrophysiological characteristics of neurons, which may be the electrophysiological mechanism of VEGF's protective effect in the early stage of ischemia.
(6) VEGF can reduce the abnormal increase of synaptic transmission in hippocampal neurons caused by hypoxia and maintain the normal synaptic transmission function of neurons, which may be one of the mechanisms that VEGF can improve synaptic plasticity and further improve cognitive function.

【學(xué)位授予單位】：南開(kāi)大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2014
【分類(lèi)號(hào)】：R-332;R318.04

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 李敬來(lái);大鼠異位心臟移植模型的建立及其現(xiàn)狀[J];上海實(shí)驗(yàn)動(dòng)物科學(xué);2001年03期

2 任志強(qiáng),劉運(yùn)良,劉麗君,王訓(xùn)凡,郭正科;三黃腎康丸治療大鼠慢性腎衰的實(shí)驗(yàn)研究[J];中國(guó)藥房;2001年01期

3 陳杰,王進(jìn)海,龔均,汪濤,程鵬;藥物干預(yù)治療大鼠混合反流性食管炎的實(shí)驗(yàn)研究[J];基礎(chǔ)醫(yī)學(xué)與臨床;2003年S1期

4 田新紅,李偉,李成文,李增富;長(zhǎng)期應(yīng)用卡馬西平對(duì)大鼠小腦結(jié)構(gòu)與功能影響的實(shí)驗(yàn)研究[J];陜西醫(yī)學(xué)雜志;2004年08期

5 馬駿,朱書(shū)秀,王彥春,甘水詠;電針對(duì)帕金森病模型大鼠黑質(zhì)多巴胺能神經(jīng)元凋亡的影響[J];上海針灸雜志;2005年10期

6 王冰;王宗仁;江山;潘惠娟;;活血化瘀類(lèi)中藥制劑對(duì)海馬缺血損傷大鼠學(xué)習(xí)記憶的影響[J];中國(guó)臨床康復(fù);2005年48期

7 徐勤;沈逸萍;許安麗;羅振亮;;SD大鼠及beagle犬腎上腺組織形態(tài)計(jì)量分析[J];中國(guó)比較醫(yī)學(xué)雜志;2006年07期

8 栗志遠(yuǎn);陸國(guó)才;袁伯俊;姜華;戴益民;佘佳紅;黃矛;;西那沙星對(duì)幼齡大鼠的軟骨毒性[J];中國(guó)新藥雜志;2006年04期

9 商常發(fā);趙芝剛;顧有方;陳會(huì)良;李衛(wèi)民;董策龍;;大棗多糖對(duì)大鼠血清鈣和葡萄糖水平的影響[J];中國(guó)中醫(yī)藥科技;2007年02期

10 王毅;林偉;施舉紅;;野百合堿處理大鼠的血清對(duì)大鼠肺動(dòng)脈壓的影響[J];中國(guó)臨床醫(yī)學(xué);2008年02期

相關(guān)會(huì)議論文 前10條

1 陳柏年;高梅;時(shí)麗麗;張恒艾;杜冠華;;匹諾塞林對(duì)大鼠全腦缺血再灌注損傷的保護(hù)作用[A];中國(guó)藥理學(xué)會(huì)第十次全國(guó)學(xué)術(shù)會(huì)議專(zhuān)刊[C];2009年

2 朱萱萱;王廣基;劉建平;王淑云;徐軒;;口腔膜治療實(shí)驗(yàn)性大鼠口腔膜潰瘍的研究[A];中國(guó)制藥工業(yè)藥理學(xué)會(huì)20周年學(xué)術(shù)會(huì)議論文集[C];2002年

3 戴文鑫;吳智勇;;慢性阻塞性肺疾病大鼠模型血清胰島素樣生長(zhǎng)因子-Ⅰ的變化[A];中華醫(yī)學(xué)會(huì)第八次全國(guó)老年醫(yī)學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2007年

4 鄺素娟;鄧春玉;張光燕;饒芳;單志新;林秋雄;楊敏;余細(xì)勇;錢(qián)衛(wèi)民;吳書(shū)林;;大蒜素對(duì)大鼠微血管張力的影響[A];第十三次全國(guó)心血管病學(xué)術(shù)會(huì)議論文集[C];2011年

5 王勁;柳啟沛;黃宗枝;;幾種不同鈣化合物對(duì)大鼠鋁、鉛代謝的影響(摘錄)[A];營(yíng)養(yǎng)健康新觀察（第三十八期）：營(yíng)養(yǎng)因素與骨髓健康[C];2009年

6 胡翔;王靜;;雌性大鼠去勢(shì)造模中設(shè)立假手術(shù)對(duì)照的必要性探討[A];全國(guó)第八次中醫(yī)婦科學(xué)術(shù)研討會(huì)論文匯編[C];2008年

7 齊偉;曾薇;龐琦;郭艷紅;牟嬌;馮兵;劉理;葉自林;袁發(fā)煥;;蛋白酶體抑制劑對(duì)大鼠糖尿病腎病的治療作用[A];第十一屆全國(guó)中西醫(yī)結(jié)合腎臟病學(xué)術(shù)會(huì)議論文匯編[C];2010年

8 梁銳;王軍波;;核苷酸喂養(yǎng)大鼠的安全性評(píng)價(jià)[A];北京市營(yíng)養(yǎng)學(xué)會(huì)第四屆會(huì)員代表大會(huì)暨膳食與健康研討會(huì)論文集[C];2010年

9 林小琪;;SD大鼠灌胃百可利30天反復(fù)給藥毒性試驗(yàn)[A];中國(guó)毒理學(xué)會(huì)第三屆中青年學(xué)者科技論壇暨2011年全國(guó)前列腺藥理毒理學(xué)研討會(huì)論文集[C];2011年

10 王曦;牛欣;羅致誠(chéng);;增齡與雄性大鼠氮氧化物及血清性激素水平變化的關(guān)系[A];全國(guó)中醫(yī)藥科研與教學(xué)改革研討會(huì)論文集[C];2002年

相關(guān)重要報(bào)紙文章 前10條

1 記者 馮衛(wèi)東;大鼠研究顯示孕期壓力或可代代相傳[N];科技日?qǐng)?bào);2014年

2 奇 云;解讀大鼠基因有助人類(lèi)攻克疑難病癥[N];大眾科技報(bào);2004年

3 張?zhí)煨?克隆大鼠意義重大[N];中國(guó)醫(yī)藥報(bào);2003年

4 本報(bào)特約撰稿人 陸志城;用大鼠還是用小鼠？[N];醫(yī)藥經(jīng)濟(jì)報(bào);2004年

5 記者 藍(lán)建中;日本研究:骨髓移植使大鼠血管“返老還童”[N];新華每日電訊;2010年

6 記者 姜澎;聰明大鼠 解密大腦記憶功能[N];文匯報(bào);2009年

7 萬(wàn)姍姍　記者 王春;轉(zhuǎn)基因“聰明大鼠”學(xué)得快記得牢[N];科技日?qǐng)?bào);2009年

8 記者 曹繼軍 顏維琦 通訊員 孫國(guó)根;大鼠基因功能圖譜被成功繪制[N];光明日?qǐng)?bào);2014年

9 記者 白毅 通訊員 孫國(guó)根;大鼠基因功能圖譜繪制成功[N];中國(guó)醫(yī)藥報(bào);2014年

10 記者 孫國(guó)根;將大鼠基因的功能“對(duì)號(hào)入座”[N];健康報(bào);2014年

相關(guān)博士學(xué)位論文 前10條

1 付德明;氯沙坦對(duì)慢性心力衰竭大鼠β_1腎上腺素能受體信號(hào)轉(zhuǎn)導(dǎo)通路與心功能的調(diào)節(jié)及其機(jī)制研究[D];山西醫(yī)科大學(xué);2009年

2 楊少兵;N-甲基-D-天冬氨酸受體2B亞基鎮(zhèn)痛疫苗應(yīng)用于大鼠的安全性評(píng)價(jià)[D];華中科技大學(xué);2009年

3 蓋建芳;低出生體重對(duì)大鼠腎臟和血壓的影響及機(jī)制研究[D];中南大學(xué);2009年

4 史敏;慢性間歇性低壓低氧抗大鼠膠原誘導(dǎo)性關(guān)節(jié)炎作用及其免疫學(xué)機(jī)制[D];河北醫(yī)科大學(xué);2011年

5 安平;柴夏煎對(duì)甲亢大鼠的影響及作用機(jī)理研究[D];黑龍江中醫(yī)藥大學(xué);2005年

6 周宜;從大鼠性周期的分子變化探討柴胡止血液的作用[D];成都中醫(yī)藥大學(xué);2005年

7 張慶紅;白細(xì)胞介素2和雌激素受體在大鼠垂體前葉的相互關(guān)系研究[D];第四軍醫(yī)大學(xué);2000年

8 張海峰;骨髓間充質(zhì)干細(xì)胞移植對(duì)大鼠急性肝功能衰竭治療作用的實(shí)驗(yàn)研究[D];山東大學(xué);2007年

9 常薪霞;鹽酸小檗堿對(duì)高脂飲食誘導(dǎo)的SD大鼠非酒精性脂肪肝的療效及機(jī)制研究[D];復(fù)旦大學(xué);2010年

10 頊紅雨;早期應(yīng)激對(duì)海馬學(xué)習(xí)、記憶功能的作用和機(jī)制研究[D];第三軍醫(yī)大學(xué);2012年

相關(guān)碩士學(xué)位論文 前10條

1 李寧;鉛、鎘、鉻、汞對(duì)大鼠聽(tīng)力的損傷及銅、錳、鋅、硒的保護(hù)作用研究[D];山東大學(xué);2008年

2 王瑩;慢性腎衰竭大鼠全段甲狀旁腺激素與心肌肌鈣蛋白的相關(guān)性分析[D];山西醫(yī)科大學(xué);2008年

3 鄧旭輝;養(yǎng)精種子湯對(duì)缺氧雄性大鼠生殖機(jī)能的影響[D];第三軍醫(yī)大學(xué);2008年

4 夏長(zhǎng)青;活血降脂靈對(duì)早期動(dòng)脈粥樣硬化大鼠的抗氧化應(yīng)激作用研究[D];河北醫(yī)科大學(xué);2009年

5 王海燕;運(yùn)動(dòng)對(duì)SD大鼠與GK大鼠骨骼肌中COUP-TF Ⅰ與COUP-TFⅡ基因表達(dá)的影響[D];華東師范大學(xué);2010年

6 吉星;知母提取物的成分分析及對(duì)T2DM大鼠干預(yù)代謝組學(xué)初探[D];廣東藥學(xué)院;2010年

7 曾志;促紅細(xì)胞生成素對(duì)新生大鼠缺氧缺血性腦損傷神經(jīng)保護(hù)作用的研究[D];暨南大學(xué);2011年

8 汪春彥;金蕎麥對(duì)克雷伯桿菌肺炎大鼠的保護(hù)作用及其機(jī)制[D];安徽醫(yī)科大學(xué);2011年

9 王媛媛;胡蘆巴總皂苷對(duì)大鼠脂肪肝的預(yù)防作用[D];新疆醫(yī)科大學(xué);2005年

10 徐莉;康復(fù)訓(xùn)練對(duì)腦梗死大鼠大腦可塑性機(jī)制的研究[D];第四軍醫(yī)大學(xué);2002年

，

本文編號(hào)：1872869